Equity Profile

A

Agilent Technologies, Inc.

Health CareLife Sciences Tools & Services$37.9B

May27Wed

Post-Earnings Recap

ReportedQ2-2026After Close4:05 PM EDT

Agilent Technologies Beats on EPS, Stock Up 0.66%

Metric	Actual	Expected	Surprise
EPS	$1.49	$1.41	+6.20%
Revenue	—	$1.8B	—

management commentary, guidance changes, and full analysis available with Pro.

Agilent Technologies Beats on EPS, Stock Up 0.66%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$1.49	$1.41	+6.20%
Revenue	—	$1.8B	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

What It Means

Agilent Technologies reported better-than-expected earnings per share, which contributed to a slight increase in the stock price. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. Investors may view the EPS beat positively, but the lack of revenue data could lead to cautious sentiment moving forward.

Company Snapshot

Agilent Technologies, Inc. is a leading player in the health care sector, specifically in life sciences tools and services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$1.41

Revenue

Total revenue reflects the company's ability to generate sales and is critical for assessing growth.

$1.8B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Agilent Technologies, Inc. is a leading player in the health care sector, specifically in life sciences tools and services. The company provides essential instruments and solutions for laboratories, which are crucial for research and development in various scientific fields. As the demand for advanced health care solutions continues to grow, Agilent's role in supporting innovation in diagnostics and pharmaceuticals becomes increasingly important.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.40%

Avg Stock Reaction

+0.42%

Last Quarter Recap

In Q1-2026, Agilent reported an EPS of $1.36, slightly missing the estimate of $1.37. The stock reacted positively, gaining 0.26% the next day.

Management Promises & Guidance

Focus on expanding product offerings in life sciences.
Commitment to enhancing customer support services.
Plans to invest in new technologies to drive growth.

Expectations

Wall Street Expectations

Analysts expect Agilent to report solid earnings this quarter, with a consensus EPS of $1.41 and revenue of $1.8 billion. The market is closely watching for any signs of growth in key segments.

Bull Case

If Agilent beats earnings expectations and shows strong revenue growth, it could indicate robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, if the company misses estimates or provides weak guidance, it may raise concerns about its growth prospects, potentially leading to a decline in stock price.

Key Metrics to Watch

EPS

$1.41

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$1.8B

Total revenue reflects the company's ability to generate sales and is critical for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Agilent's EPS exceed the consensus estimate of $1.41?

A beat on EPS could signal stronger than expected demand and operational efficiency, which would likely boost investor confidence.

What are the revenue growth rates in key segments?

Understanding growth in specific areas will help investors gauge the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Agilent's ability to capitalize on emerging trends in life sciences, particularly in diagnostics and personalized medicine.

Supporting Evidence

Agilent has consistently outperformed EPS estimates in 75% of the last eight quarters.

Options pricing suggests a larger expected move than historical averages, indicating heightened investor interest.

The company has a strong track record of innovation, which may not be fully reflected in current estimates.

Key Risk

If revenue growth in key segments exceeds expectations, it could significantly alter the current consensus outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it follows a slight miss last quarter, and any significant deviation could impact market sentiment.

Bull Confirmed If

An EPS of $1.45 or higher would confirm strong operational performance and demand.

Bear Confirmed If

An EPS below $1.39 would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±6.23%

Historical Avg

±0.5%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±4.8% while A has averaged ±0.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

34.2%

Calls (23K)P/C Ratio: 2.32Puts (29K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 15 of 30 (50%)

This setup has occurred 30 times across Health Care in the last 2 years. 15 of 30 faded and 15 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.9%, with a raw directional average of -1.9% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Agilent beats expectations, history suggests a positive stock reaction, averaging a 0.04% increase on such occasions.

In-Line / Cautious

A result in line with expectations may lead to a muted reaction, with the stock likely reflecting cautious sentiment.

Miss

If the company misses estimates, the stock could see a decline, with historical averages showing a potential drop of around 0.29%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches in life sciences tools.
2Details on customer demand trends in diagnostics.
3Any commentary on operational efficiencies or cost management.
4Insights into competitive positioning in the market.
5Guidance on future revenue growth expectations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

JOYY Inc.

Company Snapshot

Agilent Technologies, Inc. is a leading player in the health care sector, specifically in life sciences tools and services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$1.41

Revenue

Total revenue reflects the company's ability to generate sales and is critical for assessing growth.

$1.8B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.40%

Avg Stock Reaction

+0.42%

Last Quarter Recap

In Q1-2026, Agilent reported an EPS of $1.36, slightly missing the estimate of $1.37. The stock reacted positively, gaining 0.26% the next day.

Management Promises & Guidance

Focus on expanding product offerings in life sciences.
Commitment to enhancing customer support services.
Plans to invest in new technologies to drive growth.

Expectations

Wall Street Expectations

Analysts expect Agilent to report solid earnings this quarter, with a consensus EPS of $1.41 and revenue of $1.8 billion. The market is closely watching for any signs of growth in key segments.

Bull Case

If Agilent beats earnings expectations and shows strong revenue growth, it could indicate robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, if the company misses estimates or provides weak guidance, it may raise concerns about its growth prospects, potentially leading to a decline in stock price.

Key Metrics to Watch

EPS

$1.41

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$1.8B

Total revenue reflects the company's ability to generate sales and is critical for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Agilent's EPS exceed the consensus estimate of $1.41?

A beat on EPS could signal stronger than expected demand and operational efficiency, which would likely boost investor confidence.

What are the revenue growth rates in key segments?

Understanding growth in specific areas will help investors gauge the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Agilent's ability to capitalize on emerging trends in life sciences, particularly in diagnostics and personalized medicine.

Supporting Evidence

Agilent has consistently outperformed EPS estimates in 75% of the last eight quarters.

Options pricing suggests a larger expected move than historical averages, indicating heightened investor interest.

The company has a strong track record of innovation, which may not be fully reflected in current estimates.

Key Risk

If revenue growth in key segments exceeds expectations, it could significantly alter the current consensus outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it follows a slight miss last quarter, and any significant deviation could impact market sentiment.

Bull Confirmed If

An EPS of $1.45 or higher would confirm strong operational performance and demand.

Bear Confirmed If

An EPS below $1.39 would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±6.23%

Historical Avg

±0.5%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±4.8% while A has averaged ±0.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

34.2%

Calls (23K)P/C Ratio: 2.32Puts (29K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 15 of 30 (50%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Agilent beats expectations, history suggests a positive stock reaction, averaging a 0.04% increase on such occasions.

In-Line / Cautious

A result in line with expectations may lead to a muted reaction, with the stock likely reflecting cautious sentiment.

Miss

If the company misses estimates, the stock could see a decline, with historical averages showing a potential drop of around 0.29%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches in life sciences tools.
2Details on customer demand trends in diagnostics.
3Any commentary on operational efficiencies or cost management.
4Insights into competitive positioning in the market.
5Guidance on future revenue growth expectations.